Fondaparinux sodium
CAS: 114870-03-0
Molecular Formula: C31H43N3Na10O49S8
Molecular Weight:1728.0815
Product description:This product with those used in combination with drugs can increase the risk of bleeding, can increase the risk of bleeding. Oral anticoagulants (warfarin), platelet inhibitors (acetyl salicylic acid), nonsteroidal anti-inflammatory drugs (piroxicam) and digoxin pharmacokinetic does not affect the product. Used in the study of drug interactions of this product dose (10 mg) higher than the recommended dose of currently used this product indications. This product does not affect the activity of warfarin INR, also does not affect the use of acetyl salicylic acid or piroxicam treatment when the bleeding time, also does not affect the steady-state pharmacokinetics of digoxin.
Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.
for: Product Quotation ( Product suppliers),COA (Certificate of Analysis), New Sales
Promotion,New Products,And any other assistance.
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@aushealthingredients.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: